Neutrogena Rapid Clear Treatment Pads

Drug Facts

Salicylic Acid 2%

Acne medication

For the treatment of acne.

For external use only.

Flammable

Flammable – Keep away from fire or flame.

When using this product

• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. • if eye contact occurs, flush thoroughly with water.

Label information

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

• cleanse skin thoroughly before applying this product • cover the entire affected area with a thin layer one to three times daily • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Store at Room Temperature. Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing and limit sun exposure while using this product and for a week afterwards.

water, alcohol denat., butylene glycol, PPG-5-ceteth-20, C12-15 alkyl lactate, sodium citrate, cocamidopropyl PG-dimonium chloride phosphate, fragrance, PEG/PPG-20/6 dimethicone, sodium hydroxide, benzalkonium chloride, cetyl lactate, disodium EDTA

call toll-free 800-582-4048 or 215-273-8755 (collect) or visit www.neutrogena.com

Distributed by:

JOHNSON & JOHNSON CONSUMER INC.

Skillman, NJ 08558

NEUTROGENA

Rapid

Clear _®

Treatment Pads

Do Not

Flush

Neutrogena ^®

salicylic acid acne treatment

MICROCLEAR ^TM

technology

helps stop emerging

breakouts

reduces breakouts in

8 HOURS

MAXIMUM STRENGTH

• Deep cleans dirt and oil.
• Leaves skin clean and smooth.

60 PADS

2.12 in. (5.50cm) DIA

[Image in the official label — see DailyMed source]